0001622240-17-000001.txt : 20170317 0001622240-17-000001.hdr.sgml : 20170317 20170317143405 ACCESSION NUMBER: 0001622240-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170317 DATE AS OF CHANGE: 20170317 EFFECTIVENESS DATE: 20170317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Supreme Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001622240 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-282836 FILM NUMBER: 17697501 BUSINESS ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 BUSINESS PHONE: 604-674-2191 MAIL ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 D 1 primary_doc.xml X0707 D LIVE 0001622240 Supreme Pharmaceuticals Inc. 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 647-525-5463 BRITISH COLUMBIA, CANADA Supreme Resources Ltd. None Corporation true John Fowler 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Executive Officer Director President and Chief Executive Officer Michael La Brier 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Director Chairman Scott Walters 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Director Navdeep Dhaliwal 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Executive Officer Director Chief Financial Officer Chuck Rifici 202 - 20 De Boers Drive Toronto A6 ONTARIO, CANADA M3J 0H1 Director Pharmaceuticals Decline to Disclose 06b false 2016-12-13 false true true true false 0 Canaccord Genuity Corp. None Canaccord Genuity Inc. 1020 535 Madison Avenue Second Floor New York NY NEW YORK 10022 NY NEW YORK true Dundee Securities Ltd. None None None 1 Adelaide Street East Suite 2000 Toronto A6 ONTARIO, CANADA M5C 2V9 NY NEW YORK true Beacon Securities Limited None None None 200 Bay Street Suite 2800, South Tower Toronto A6 ONTARIO, CANADA M5J 2J2 NY NEW YORK true Cormark Securities Inc. None None None 66 Wellington Street West Suite 4050 Toronto A6 ONTARIO, CANADA M5K 1H1 NY NEW YORK true 369667 369667 0 Total sold in the US was USD$369,667 (based on the conversion of Canadian dollars to USD at an exchange rate of CDN$1.00=USD$0.7622, the Bank of Canada noon exchange rate on 12/13/16). An additional USD$41,551,333 was sold outside of the US under Reg. S. false 1 19400 0 Canadian dollars converted to US dollars at an exchange rate of CDN$1.00 = USD$0.7622 (the Bank of Canada noon exchange rate on 12/13/16). 0 false Supreme Pharmaceuticals Inc. John Fowler John Fowler President and Chief Executive Officer 2017-03-17